Boundless Bio to Present at the Citi 15th Annual BioPharma Virtual Conference

Sept. 3, 2020 13:00 UTC

 

 
 

SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a company developing innovative new therapies directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced it will present a corporate overview at Citi’s 15th Annual BioPharma Virtual Conference.

Date: Tuesday, September 8th
Time: 4:40 p.m. EDT
Presenter: Zachary Hornby, President and Chief Executive Officer of Boundless Bio

About Boundless Bio

Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.

For more information, visit www.boundlessbio.com.

Follow us on LinkedIn and Twitter.

Contacts

Sarah Sutton
Glover Park Group
ssutton@gpg.com
202-337-0808

Danielle Cantey
Glover Park Group
dcantey@gpg.com
202-337-0808

 
 

Source: Boundless Bio

Back to news